KIMS rallies 6%, hits 52-week high after Q2 results
Kotak Institutional Equities initiated coverage on KIMS with a buy rating and a target price of Rs 1,590. “Armed with a solid execution track record, a calibrated expansion approach, and a healthy balance sheet, KIMS is well positioned to build on its strong hospital network in AP/Telangana with entries in neighbouring states,” the brokerage said.
